People who eat more olive oil have lower cholesterol, lower blood sugar, and lower blood pressure. This comes from a study of about 4,900 Italian adults aged 20-59 who were all examined at one point in time.
See the scientific wording
Higher olive oil consumption is associated with lower serum cholesterol, lower blood glucose, and lower systolic blood pressure in both men and women, based on a cross-sectional analysis of 4,903 Italian adults aged 20-59.
Indication only — weak evidence
ObservationalOne low-scoring study points this way, but the evidence is still early.
What the research says
1 study reviewedSupporting (1)
Cross-Sectional StudyHuman1990
The study found a significant inverse association between olive oil intake and multiple cardiovascular risk factors in both sexes, supporting the claim that olive oil is linked to a healthier risk profile.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Eating olive oil gives the body healthy fats and special plant chemicals. These chemicals help reduce damage to cells and lower swelling inside the body. When there is less swelling, the body's cells respond better to insulin, which helps sugar get into cells and lowers blood sugar. Less swelling also tells the liver to make less cholesterol and remove more cholesterol from the blood. And less swelling helps blood vessels relax, which lowers blood pressure.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
People who eat more olive oil have lower cholesterol, lower blood sugar, and lower blood pressure. This comes from a study of about 4,900 Italian adults aged 20-59 who were all examined at one point in time.
Mechanism
1 studyEating olive oil gives the body healthy fats and plant chemicals that reduce damage and swelling. Less swelling helps the body use sugar better, makes less cholesterol, and relaxes blood vessels, so blood sugar, cholesterol, and blood pressure go down.
Eating olive oil gives the body healthy fats and special plant chemicals. These chemicals help reduce damage to cells and lower swelling inside the body. When there is less swelling, the body's cells respond better to insulin, which helps sugar get into cells and lowers blood sugar. Less swelling also tells the liver to make less cholesterol and remove more cholesterol from the blood. And less swelling helps blood vessels relax, which lowers blood pressure.
Olive oil provides monounsaturated fatty acids (oleic acid) and polyphenols (hydroxytyrosol, oleuropein) that are absorbed into the bloodstream.
Polyphenols activate the Nrf2 transcription factor, increasing expression of antioxidant enzymes such as superoxide dismutase and catalase, reducing oxidative stress.
Reduced oxidative stress lowers the production of pro-inflammatory cytokines (e.g., TNF-α, IL-6) by immune cells.
Lower inflammation improves insulin receptor signaling in skeletal muscle and adipose tissue, enhancing glucose transporter (GLUT4) translocation and glucose uptake, thereby lowering blood glucose.
Improved insulin sensitivity reduces hepatic gluconeogenesis and increases peripheral glucose disposal, further lowering blood glucose.
Reduced inflammation and improved insulin signaling downregulate HMG-CoA reductase activity in the liver, decreasing cholesterol synthesis, and upregulate LDL receptor expression, increasing LDL clearance from circulation, lowering serum cholesterol.
Reduced oxidative stress and inflammation enhance endothelial nitric oxide synthase (eNOS) activity, increasing nitric oxide production, which relaxes vascular smooth muscle and lowers systolic blood pressure.
Evidence from Studies
Supporting (1)
Community contributions welcome
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Meta-Analysis of Randomized Controlled Trials on Olive Oil and Cardiometabolic Risk Factors
Comprehensive search of PubMed, Embase, and Cochrane databases for RCTs comparing olive oil-enriched diets to control diets, with meta-analysis of pooled effect sizes for serum cholesterol, fasting glucose, and systolic blood pressure outcomes.
Randomized Controlled Trial of High-Olive-Oil Mediterranean Diet vs Low-Fat Diet on Lipid and Glucose Profiles
Randomized, controlled, parallel-group trial in 500 adults aged 20-59 with elevated cardiometabolic risk, assigned to either a Mediterranean diet supplemented with 50 mL/day extra-virgin olive oil or a low-fat control diet for 12 months, with serum cholesterol, fasting glucose, and systolic blood pressure measured at baseline, 6, and 12 months.
Prospective Cohort Study of Olive Oil Intake and Incident Dyslipidemia, Hyperglycemia, and Hypertension
Prospective cohort of 10,000 adults aged 20-59 without baseline metabolic disease, with validated food frequency questionnaires at baseline and annual serum lipid, glucose, and blood pressure measurements over 10 years, adjusting for confounders including total fat intake, physical activity, and BMI.
Cross-Sectional Analysis of Olive Oil Consumption and Cardiometabolic Markers in Italian Adults
Cross-sectional analysis of 4,903 Italian adults aged 20-59 with dietary assessment via food frequency questionnaire and concurrent measurement of serum cholesterol, fasting blood glucose, and systolic blood pressure, with multivariable adjustment for age, sex, BMI, smoking, and physical activity.